A multinational research team led by Columbia University and the La Jolla Institute for Immunology has identified a novel viral target that could help combat the global resurgence of measles.
A new study shows that an ancient mechanism of regulating a cell’s protein repertoire allows malaria parasites to hide from fast-acting artemisinin drugs and survive.
Telemedicine as a way to deliver health care is here to stay. Columbia physicians are working together with members of the engineering and business schools to advance implementation of telemedicine.
What was learned by researchers during the pandemic has changed the mindset for scientists: “Why do we have to follow the old routine when we see a new paradigm working so well?”
Children were spared the worst of COVID-19 early on, but they are now suffering psychological consequences from the pandemic’s social upheaval. Here’s what parents and educators can do.
The COVID pandemic transformed students’ education but also imparted profound experiences that students say will make them stronger practitioners and leaders.
Columbia health care workers tell us about the pandemic’s toll on their lives and what CUIMC is doing to alleviate the burden. Emotional support, self-care, and instilling hope are key.
New insights by Columbia researchers into MIS-C, a rare but serious complication of COVID in children, may lead to faster diagnosis and better treatment.
COVID vaccines and monoclonal antibody treatments offer less protection against new omicron subvariants, a new study from researchers at Columbia and University of Hong Kong finds.
Columbia researchers could receive up to $9.4 million to learn about long COVID in children and young adults as part of NIH’s REsearching COVID to Enhance Recovery (RECOVER) initiative.
A common virus that causes no harm in most people may be a danger to organ transplant recipients and other immunocompromised people, Columbia University researchers have found.